Indication

Sialorrhea

Sialorrhea, also known as hypersalivation or drooling, is the unintentional pooling and spillage of saliva beyond the oral cavity or into the posterior pharynx. Read more about Sialorrhea

37 drugs 36 manufacturers

Advertisement

Drugs that treat it

Common Sialorrhea therapies.

Showing 1–9 of 37 drugs

Filter & compare in the drug finder →Opens the drug finder with Sialorrhea preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Sialorrhea.

Sialorrhea, also known as hypersalivation or drooling, is the unintentional pooling and spillage of saliva beyond the oral cavity or into the posterior pharynx.

Although common and physiologically benign in infants, it is considered abnormal after approximately four years of age and most frequently affects pediatric and adult populations with neuromuscular or neurodegenerative disorders, such as cerebral palsy, Parkinson’s disease, and amyotrophic lateral sclerosis.

Pathophysiologically, the condition is rarely caused by absolute salivary hypersecretion; instead, it typically stems from impaired swallowing mechanisms, deficient neuromuscular control of the tongue and facial musculature, sensory deficits, or postural abnormalities.

If left unmanaged, persistent sialorrhea can cause perioral skin breakdown, impaired speech, dehydration, social stigmatization, and chronic aspiration leading to recurrent respiratory infections.

Personalize your experience

Follow Sialorrhea and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it